Journal of Gastroenterology and Digestive Diseases

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Mini Review - Journal of Gastroenterology and Digestive Diseases (2024) Volume 9, Issue 2

Impact of medications on digestive bleeding risks

Simon Veitch *

Faculty of Medicine, University of Helsinki, Finland

*Corresponding Author:
Simon Veitch
Faculty of Medicine, University of Helsinki, Finland
E-mail: simon@flnd.edu.in

Received: 24-Feb-2024, Manuscript No. JGDD-24-136138; Editor assigned: 26-Feb-2024, PreQC No. JGDD-24-136138(PQ); Reviewed: 11-Mar-2024, QC No. JGDD-24-136138; Revised: 16-Mar-2024, Manuscript No. JGDD-24-136138(R); Published: 23-Mar-2024, DOI: 10.35841/jgdd -9.2.195

Citation: : Veitch S. Impact of medications on digestive bleeding risks. J Gastroenterol Dig Dis.2024;9(2):195

Visit for more related articles at Journal of Gastroenterology and Digestive Diseases

Introduction

Medications play a significant role in the development of digestive bleeding, influencing both the upper and lower gastrointestinal tract. Understanding the risks associated with different classes of medications is crucial for healthcare providers to make informed decisions and for patients to take preventive measures. This article explores the impact of medications on digestive bleeding risks, focusing on common culprits and preventive strategies [1].

Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Mechanism: NSAIDs inhibit cyclooxygenase (COX) enzymes, leading to reduced production of prostaglandins, which are protective for the stomach lining. Risk: Increased risk of peptic ulcers and upper gastrointestinal bleeding (UGIB), especially with prolonged use or in high doses. Examples: Ibuprofen, naproxen, aspirin (at high doses) [2].

Anticoagulants and Antiplatelet Agents: Mechanism: These medications interfere with blood clotting mechanisms, increasing the risk of bleeding throughout the gastrointestinal tract. Risk: Higher risk of both upper and lower gastrointestinal bleeding, particularly with long-term use or in patients with underlying gastrointestinal conditions. Examples: Warfarin, heparin, direct oral anticoagulants (DOACs), aspirin (low dose) [3].

Corticosteroids: Mechanism: Corticosteroids can increase gastric acid secretion and decrease mucosal blood flow, predisposing to gastric ulceration. Risk: Increased risk of both upper and lower gastrointestinal bleeding, especially with high doses or prolonged use. Examples: Prednisone, dexamethasone [4].

Antibiotics: Mechanism: Some antibiotics, particularly broad-spectrum agents, can disrupt the normal gut flora and increase susceptibility to infections like Clostridium difficile colitis, which can cause lower gastrointestinal bleeding. Risk: Increased risk of infectious colitis and subsequent bleeding. Examples: Fluoroquinolones, clindamycin [5].

Potassium Supplements: Mechanism: Potassium supplements, especially in solid form, can cause irritation to the gastrointestinal tract, leading to ulceration and bleeding. Risk: Increased risk of upper gastrointestinal bleeding. Examples: Potassium chloride [6].

Prevention and Management Strategies: To mitigate the risks associated with medications and digestive bleeding, several preventive strategies can be implemented: Assessment of Risk Factors: Identify and assess patient-specific risk factors, such as age, history of peptic ulcers, liver disease, and concomitant medications. Consider alternative medications or lower doses in high-risk patients [7].

Use of Proton Pump Inhibitors (PPIs): Prophylactic use of PPIs can reduce the risk of NSAID-induced ulcers and upper gastrointestinal bleeding. PPIs help by reducing gastric acid production, which protects the gastric mucosa from damage. H2-Receptor Antagonists: Another option for reducing acid production and preventing NSAID-induced ulcers, though not as potent as PPIs. Consideration of COX-2 Inhibitors: COX-2 inhibitors have a lower risk of causing gastrointestinal ulcers compared to traditional NSAIDs but still carry some risk, especially with long-term use [8].

Monitoring and Surveillance: Monitor patients regularly for signs and symptoms of gastrointestinal bleeding, especially in those on long-term therapy or with additional risk factors. Educate patients about the signs of bleeding and when to seek medical attention [9].

Hydration and Food Intake: Taking medications with food or milk can help reduce the risk of gastric irritation. Ensuring adequate hydration can also help protect the gastric mucosa. Adjustment of Anticoagulant Therapy: Regular monitoring of anticoagulant therapy and adjustment of doses to maintain therapeutic levels while minimizing bleeding risk. onsideration of reversal agents in cases of acute bleeding [10].

Conclusion

Medications can significantly impact the risk of digestive bleeding, affecting both the upper and lower gastrointestinal tracts through various mechanisms. It is essential for healthcare providers to be aware of these risks and to implement preventive strategies to minimize patient harm. This includes assessing patient-specific risk factors, considering alternative medications, using gastroprotective agents like PPIs, and monitoring patients for signs of bleeding. By taking a proactive approach to medication management and patient education, healthcare providers can reduce the incidence and severity of medication-induced digestive bleeding, ultimately improving patient safety and outcomes.

References

  1. Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(2):14-20.

    2. Indexed at, Google Scholar, Cross Ref

  2. Coulthard P, Bailey E, Esposito M, et al. Surgical techniques for the removal of mandibular wisdom teeth. Cochrane Database Syst Rev. 2014(7).

    3. Indexed at, Google Scholar, Cross Ref

  3. Zuccaro G. Epidemiology of lower gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):225-32.

    4. Indexed at, Google Scholar, Cross Ref

  4. Lavikainen LI, Guyatt GH, Kalliala IE, et al. Risk of thrombosis and bleeding in gynecologic noncancer surgery: systematic review and meta-analysis. Am J Obstet Gynecol. 2023.

    5. Indexed at, Google Scholar, Cross Ref

  5. Parikh NS, Basu E, Hwang MJ, et al. Management of stroke in patients with chronic liver disease: a practical review. Stroke. 2023;54(9):2461-71.

    6. Indexed at, Google Scholar, Cross Ref

  6. Lavikainen LI, Guyatt GH, Kalliala IE, et al. Risk of thrombosis and bleeding in gynecologic noncancer surgery: systematic review and meta-analysis. Am J Obstet Gynecol. 2023.

    7. Indexed at, Google Scholar, Cross Ref

  7. Odewole M, Sen A, Okoruwa E, et al. Systematic review with meta?analysis: incidence of variceal hemorrhage in patients with cirrhosis undergoing transesophageal echocardiography. Aliment Pharmacol Ther. 2022;55(9):1088-98.

    8. Indexed at, Google Scholar, Cross Ref

  8. Yung DE, Koulaouzidis A, Avni T, et al. Clinical outcomes of negative small-bowel capsule endoscopy for small-bowel bleeding: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85(2):305-17.

    9. Indexed at,Google Scholar, Cross Ref

  9. Van Rooijen SJ, Huisman D, Stuijvenberg M, et al. Intraoperative modifiable risk factors of colorectal anastomotic leakage: why surgeons and anesthesiologists should act together. Int J Surg. 2016;36:183-200.

    10. Indexed at, Google Scholar, Cross Ref

  10. Gonçalves TC, de Castro FD, Moreira MJ, et al. Small bowel capsule endoscopy in obscure gastrointestinal bleeding: normalcy is not reassuring. Eur J Gastroenterol Hepatol. 2014;26(8):927-32.

    11. Indexed at, Google Scholar, Cross Ref

Get the App